255
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Mechanism of Xiaoyao San in treating non-alcoholic fatty liver disease with liver depression and spleen deficiency: based on bioinformatics, metabolomics and in vivo experiments

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 5128-5146 | Received 20 Jan 2023, Accepted 08 Jun 2023, Published online: 13 Jul 2023

References

  • Amberger, J. S., Bocchini, C. A., Scott, A. F., & Hamosh, A. (2019). OMIM.org: Leveraging knowledge across phenotype-gene relationships. Nucleic Acids Research, 47(D1), D1038–D1043. https://doi.org/10.1093/nar/gky1151
  • Baldeón Rojas, L., Weigelt, K., de Wit, H., Ozcan, B., van Oudenaren, A., Sempértegui, F., Sijbrands, E., Grosse, L., van Zonneveld, A.-J., Drexhage, H. A., & Leenen, P. J. M. (2016). Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D. Diabetology & Metabolic Syndrome, 8(1), 6. https://doi.org/10.1186/s13098-015-0113-5
  • Bloyd, M., Settas, N., Faucz, F. R., Sinaii, N., Bathon, K., Iben, J., Coon, S., Caprio, S., Stratakis, C. A. & London, E. (2021). The PRKAR1B p.R115K variant is associated with lipoprotein profile in African American youth with metabolic challenges. Journal of the Endocrine Society, 5(8), bvab071.
  • Chong, J., & Xia, J. (2020). Using MetaboAnalyst 4.0 for metabolomics data analysis, interpretation, and integration with other omics data. Methods in Molecular Biology (Clifton, N.J.), 2104, 337–360. https://doi.org/10.1007/978-1-0716-0239-3_17
  • Deng, X., Ke, X., Tang, Y., Luo, W., Dong, R., Ge, D., Han, L., Yang, Y., Liu, H., Reyila, T., & Liao, Y. (2020). Sagittaria sagittifolia polysaccharide interferes with arachidonic acid metabolism in non-alcoholic fatty liver disease mice via Nrf2/HO-1 signaling pathway. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 132, 110806. https://doi.org/10.1016/j.biopha.2020.110806
  • Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003). DAVID: Database for annotation, visualization, and integrated discovery. Genome Biology, 4(5), P3. https://doi.org/10.1186/gb-2003-4-5-p3
  • Dogan, Z., Kutluay, V. M., Genc, Y., & Saracoglu, I. (2023). Interactions between phenolic constituents of Scutellaria salviifolia and key targets associated with inflammation: Network pharmacology, molecular docking analysis and in vitro assays. Journal of Biomolecular Structure & Dynamics, 41(4), 1281–1294. https://doi.org/10.1080/07391102.2021.2019119
  • Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., Haselden, J. N., Nicholls, A. W., Wilson, I. D., Kell, D. B., & Goodacre, R. (2011). Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols, 6(7), 1060–1083. https://doi.org/10.1038/nprot.2011.335
  • Gallagher, E. J., & LeRoith, D. (2015). Obesity and diabetes: The increased risk of cancer and cancer-related mortality. Physiological Reviews, 95(3), 727–748. https://doi.org/10.1152/physrev.00030.2014
  • Gurgul-Convey, E., & Lenzen, S. (2010). Protection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin-producing cells. The Journal of Biological Chemistry, 285(15), 11121–11128. https://doi.org/10.1074/jbc.M109.054775
  • Hsieh, P. S., Jin, J. S., Chiang, C. F., Chan, P. C., Chen, C. H., & Shih, K. C. (2009). COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring, Md.), 17(6), 1150–1157. https://doi.org/10.1038/oby.2008.674
  • Huang, Z., Hou, Z., Liu, X., Liu, F., & Wu, Y. (2018). Quantifying liver stagnation spleen deficiency pattern for diarrhea predominate irritable bowel syndromes using multidimensional analysis methods. Evidence-Based Complementary and Alternative Medicine : eCAM, 2018, 6467135. https://doi.org/10.1155/2018/6467135
  • Huby, T., & Gautier, E. L. (2022). Immune cell-mediated features of non-alcoholic steatohepatitis. Nature Reviews. Immunology, 22(7), 429–443. https://doi.org/10.1038/s41577-021-00639-3
  • Hundertmark, J., Krenkel, O., & Tacke, F. (2018). Adapted immune responses of myeloid-derived cells in fatty liver disease. Frontiers in Immunology, 9, 2418. https://doi.org/10.3389/fimmu.2018.02418
  • Izzi-Engbeaya, C., Comninos, A. N., Clarke, S. A., Jomard, A., Yang, L., Jones, S., Abbara, A., Narayanaswamy, S., Eng, P. C., Papadopoulou, D., Prague, J. K., Bech, P., Godsland, I. F., Bassett, P., Sands, C., Camuzeaux, S., Gomez-Romero, M., Pearce, J. T. M., Lewis, M. R., … Dhillo, W. S. (2018). The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans. Diabetes, Obesity & Metabolism, 20(12), 2800–2810. https://doi.org/10.1111/dom.13460
  • Kamburov, A., Cavill, R., Ebbels, T. M., Herwig, R., & Keun, H. C. (2011). Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics (Oxford, England), 27(20), 2917–2918. https://doi.org/10.1093/bioinformatics/btr499
  • Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Research, 28(1), 27–30. https://doi.org/10.1093/nar/28.1.27
  • Kind, T., Wohlgemuth, G., Lee, D. Y., Lu, Y., Palazoglu, M., Shahbaz, S., & Fiehn, O. (2009). FiehnLib: Mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Analytical Chemistry, 81(24), 10038–10048. https://doi.org/10.1021/ac9019522
  • Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., Francque, S., George, J., Hagström, H., Huang, T. T.-K., Ismail, M. H., Kautz, A., Sarin, S. K., Loomba, R., Miller, V., … Zelber-Sagi, S. (2022). Advancing the global public health agenda for NAFLD: A consensus statement. Nature Reviews. Gastroenterology & Hepatology, 19(1), 60–78. https://doi.org/10.1038/s41575-021-00523-4
  • Li, X.-J., Qiu, W.-Q., Da, X.-L., Hou, Y.-J., Ma, Q.-Y., Wang, T.-Y., Zhou, X.-M., Song, M., Bian, Q.-L., & Chen, J.-X. (2020). A combination of depression and liver Qi stagnation and spleen deficiency syndrome using a rat model. Anatomical Record (Hoboken, N.J. : 2007), 303(8), 2154–2167. https://doi.org/10.1002/ar.24388
  • Liu, T.-H., Chen, W.-H., Chen, X.-D., Liang, Q.-E., Tao, W.-C., Jin, Z., Xiao, Y., & Chen, L.-G. (2020). Network pharmacology identifies the mechanisms of action of TaohongSiwu decoction against essential hypertension. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 26, e920682. https://doi.org/10.12659/MSM.920682
  • Liu, C., Liao, J. Z., & Li, P. Y. (2017). Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. World Journal of Gastroenterology, 23(11), 1964–1973. https://doi.org/10.3748/wjg.v23.i11.1964
  • Liu, N., Yang, J., Ma, W., Li, C., An, L., Zhang, X., & Zou, Q. (2022). Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Ethnopharmacology, 288, 114999. https://doi.org/10.1016/j.jep.2022.114999
  • Mayneris-Perxachs, J., & Swann, J. R. (2019). Metabolic phenotyping of malnutrition during the first 1000 days of life. European Journal of Nutrition, 58(3), 909–930. https://doi.org/10.1007/s00394-018-1679-0
  • Meng, Z. Z., Chen, J. X., Jiang, Y. M., & Zhang, H. T. (2013). Effect of xiaoyaosan decoction on learning and memory deficit in rats induced by chronic immobilization stress. Evidence-Based Complementary and Alternative Medicine : eCAM, 2013, 297154. https://doi.org/10.1155/2013/297154
  • Milano, M. (2022). Using gene ontology to annotate and prioritize microarray data. Methods in Molecular Biology (Clifton, N.J.), 2401, 273–287. https://doi.org/10.1007/978-1-0716-1839-4_18
  • Qiu, J., Shi, Z., & Jiang, J. (2017). Cyclooxygenase-2 in glioblastoma multiforme. Drug Discovery Today, 22(1), 148–156. https://doi.org/10.1016/j.drudis.2016.09.017
  • Rao, S., Huang, J., Shen, Z., Xiang, C., Zhang, M., & Lu, X. (2019). Inhibition of TREM-1 attenuates inflammation and lipid accumulation in diet-induced nonalcoholic fatty liver disease. Journal of Cellular Biochemistry, 120(7), 11867–11877. https://doi.org/10.1002/jcb.28468
  • Rong, L., Zou, J., Ran, W., Qi, X., Chen, Y., Cui, H., & Guo, J. (2022). Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Frontiers in Endocrinology, 13, 1087260. https://doi.org/10.3389/fendo.2022.1087260
  • Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., Xu, X., Li, Y., Wang, Y., & Yang, L. (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6, 13. https://doi.org/10.1186/1758-2946-6-13
  • Ruan, X., Du, P., Zhao, K., Huang, J., Xia, H., Dai, D., Huang, S., Cui, X., Liu, L., & Zhang, J. (2020). Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking. Chinese Medicine, 15, 62. https://doi.org/10.1186/s13020-020-00346-6
  • Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504. https://doi.org/10.1101/gr.1239303
  • Shi, K., Li, R., Xu, Z., & Zhang, Q. (2020). Identification of crucial genetic factors, such as PPARγ, that regulate the pathogenesis of fatty liver disease in dairy cows is imperative for the sustainable development of dairy industry. Animals, 10(4), 639. https://doi.org/10.3390/ani10040639
  • Stelzer, G., Rosen, N., Plaschkes, I., Zimmerman, S., Twik, M., Fishilevich, S., Stein, T. I., Nudel, R., Lieder, I., Mazor, Y., & Kaplan, S. (2016). The GeneCards Suite: From gene data mining to disease genome sequence analyses. Current Protocols in Bioinformatics, 54, 1.30.1–1.30.33.
  • Sveinbjornsson, G., Ulfarsson, M. O., Thorolfsdottir, R. B., Jonsson, B. A., Einarsson, E., Gunnlaugsson, G., Rognvaldsson, S., Arnar, D. O., Baldvinsson, M., Bjarnason, R. G., Eiriksdottir, T., Erikstrup, C., Ferkingstad, E., Halldorsson, G. H., Helgason, H., Helgadottir, A., Hindhede, L., Hjorleifsson, G., Jones, D., … Stefansson, K. (2022). Multiomics study of nonalcoholic fatty liver disease. Nature Genetics, 54(11), 1652–1663. https://doi.org/10.1038/s41588-022-01199-5
  • Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., Bork, P., Jensen, L. J., & von Mering, C. (2023). The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research, 51(D1), D638–D646. https://doi.org/10.1093/nar/gkac1000
  • Sztolsztener, K., Chabowski, A., Harasim-Symbor, E., Bielawiec, P., & Konstantynowicz-Nowicka, K. (2020). Arachidonic acid as an early indicator of inflammation during non-alcoholic fatty liver disease development. Biomolecules, 10(8), 1133. https://doi.org/10.3390/biom10081133
  • Tsujimoto, S., Kishina, M., Koda, M., Yamamoto, Y., Tanaka, K., Harada, Y., Yoshida, A., & Hisatome, I. (2016). Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ. International Journal of Molecular Medicine, 38(3), 721–728. https://doi.org/10.3892/ijmm.2016.2674
  • Wang, D., Fu, L., Sun, H., Guo, L., & DuBois, R. N. (2015). Prostaglandin E2 promotes colorectal cancer stem cell expansion and metastasis in mice. Gastroenterology, 149(7), 1884–1895.e4. https://doi.org/10.1053/j.gastro.2015.07.064
  • Wang, Z., Li, S., Wang, R., Guo, L., Xu, D., Zhang, T., Xu, Y., Wang, W., Wang, M., Gan, Z., & Wang, X. (2020). The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). Molecular Medicine (Cambridge, Mass.), 26(1), 54. https://doi.org/10.1186/s10020-020-00164-4
  • Wang, S., Ma, J., Zeng, Y., Zhou, G., Wang, Y., Zhou, W., Sun, X., & Wu, M. (2021). Icariin, an up-and-coming bioactive compound against neurological diseases: Network pharmacology-based study and literature review. Drug Design, Development and Therapy, 15, 3619–3641. https://doi.org/10.2147/DDDT.S310686
  • Wang, W., Wang, S., Liu, T., Ma, Y., Huang, S., Lei, L., Wen, A., & Ding, Y. (2020). Resveratrol: Multi-targets mechanism on neurodegenerative diseases based on network pharmacology. Frontiers in Pharmacology, 11, 694. https://doi.org/10.3389/fphar.2020.00694
  • Wilkinson, D. J., Rodriguez-Blanco, G., Dunn, W. B., Phillips, B. E., Williams, J. P., Greenhaff, P. L., Smith, K., Gallagher, I. J., & Atherton, P. J. (2020). Untargeted metabolomics for uncovering biological markers of human skeletal muscle ageing. Aging, 12(13), 12517–12533. https://doi.org/10.18632/aging.103513
  • Wong, V. W.-S., Chan, W.-K., Chitturi, S., Chawla, Y., Dan, Y. Y., Duseja, A., Fan, J., Goh, K.-L., Hamaguchi, M., Hashimoto, E., Kim, S. U., Lesmana, L. A., Lin, Y.-C., Liu, C.-J., Ni, Y.-H., Sollano, J., Wong, S. K.-H., Wong, G. L.-H., Chan, H. L.-Y., & Farrell, G. (2018). Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment. Journal of Gastroenterology and Hepatology, 33(1), 70–85. https://doi.org/10.1111/jgh.13857
  • Yang, C., Hao, R., Du, X., Wang, Q., Deng, Y., & Sun, R. (2019). Response to different dietary carbohydrate and protein levels of pearl oysters (Pinctada fucata martensii) as revealed by GC-TOF/MS-based metabolomics. The Science of the Total Environment, 650(Pt 2), 2614–2623. https://doi.org/10.1016/j.scitotenv.2018.10.023
  • You, J. S., Li, C. Y., Chen, W., Chen, W., Wu, X.-L., Huang, L.-J., Li, R.-K., Gao, F., Zhang, M.-Y., Liu, H.-L., & Qu, W.-L. (2020). A network pharmacology-based study on Alzheimer disease prevention and treatment of Qiong Yu Gao. BioData Mining, 13, 2.
  • Yuan, N., Gong, L., Tang, K., He, L., Hao, W., Li, X., Ma, Q., & Chen, J. (2020). An integrated pharmacology-based analysis for antidepressant mechanism of Chinese Herbal Formula Xiao-Yao-San. Frontiers in Pharmacology, 11, 284. https://doi.org/10.3389/fphar.2020.00284
  • Zhang, T., Au Yeung, S. L., & Schooling, C. M. (2021). Associations of arachidonic acid synthesis with cardiovascular risk factors and relation to ischemic heart disease and stroke: A univariable and multivariable Mendelian randomization study. Nutrients, 13(5), 1489. https://doi.org/10.3390/nu13051489
  • Zhang, Y., Chen, M-l., Zhou, Y., Yi, L., Gao, Y-x., Ran, L., Chen, S-h., Zhang, T., Zhou, X., Zou, D., Wu, B., Wu, Y., Chang, H., Zhu, J-d., Zhang, Q-y., & Mi, M-t (2015). Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway. Molecular Nutrition & Food Research, 59(8), 1443–1457. https://doi.org/10.1002/mnfr.201500016
  • Zhao, E., Cheng, Y., Yu, C., Li, H., & Fan, X. (2023). The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease. Annals of Medicine, 55(1), 2197652.
  • Zheng, Y., Ching, J., Cheng, C. W., Lam, W. C., Chan, K. L., Zhang, X., Lam, P. Y., Wu, X. Y., Zhong, L. L. D., Cao, P. H., Lo, C. W., Cheong, P. K., Lin, Z., Koh, M., Wu, J., & Bian, Z. X. (2021). Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: Study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial. Chinese Medicine, 16(1), 117. https://doi.org/10.1186/s13020-021-00530-2
  • Zhu, A. S., Li, A., Ratliff, T. S., Melsom, M., & Garza, L. A. (2017). After skin wounding, noncoding dsRNA coordinates prostaglandins and Wnts to promote regeneration. The Journal of Investigative Dermatology, 137(7), 1562–1568. https://doi.org/10.1016/j.jid.2017.03.023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.